Similar articles

• FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure.

  Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisaoka T, Obayashi M, Ohkusa T, Kohno M, Matsuzaki M. Yano M, et al. Circulation. 2003 Jan 28;107(3):477-84. doi: 10.1161/01.cir.0000044917.74408.be. Circulation. 2003. PMID: 12551874
• Novel therapeutic approaches for heart failure by normalizing calcium cycling.

  Wehrens XH, Marks AR. Wehrens XH, et al. Nat Rev Drug Discov. 2004 Jul;3(7):565-73. doi: 10.1038/nrd1440. Nat Rev Drug Discov. 2004. PMID: 15232578 Review. No abstract available.
• A guide for the perplexed: towards an understanding of the molecular basis of heart failure.

  Marks AR. Marks AR. Circulation. 2003 Mar 25;107(11):1456-9. doi: 10.1161/01.cir.0000059745.95643.83. Circulation. 2003. PMID: 12654597 No abstract available.
• Sarcoplasmic reticulum calcium release function and FK binding proteins in heart failure: another piece of a complex jigsaw.

  Terracciano CM. Terracciano CM. Cardiovasc Res. 2000 Nov;48(2):191-3. doi: 10.1016/s0008-6363(00)00207-8. Cardiovasc Res. 2000. PMID: 11054466 No abstract available.
• Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death.

  Phrommintikul A, Chattipakorn N. Phrommintikul A, et al. Int J Cardiol. 2006 Sep 20;112(2):142-52. doi: 10.1016/j.ijcard.2005.11.106. Epub 2006 May 15. Int J Cardiol. 2006. PMID: 16701909 Review.